SlideShare a Scribd company logo
1 of 53
LEUKEMIA
BLOOD CANCER OF BLOOD FORMING TISSUES
DEFINITION
Un controlled
neoplastic proliferation of
leucocyte precursors
INCIDENCE
Most common
malignancy of children
less than 15 years of age
Peak incidence is at 4
years of age
CAUSES
Virus papilloma virus ,epstein
barr virus,radiations
Exposure to chemicals drug
like
 Benzene
 dilantin
CLASSIFICATION
 Leukemia can be classified as follows
leukemia
Acute Chronic
Acute Acute myeloid leukaemia
lymphoid
leukaemia
Chronic
Chronic lymphoid Chronic myloid
leukemia
leukemia
T-cell Bcell pre B cell null cell
 Acute myeloid leukemia
Acute Acute Acute myelo mono Myeloblastic
promyelocytic cytic
acute mono cytic Acute
erythro
cytic
Leukaemia can be classified according to pre dominent
cell type and level of cell maturity as:
 lympho It means leukemia involving
the lymphoid series
 Myelo It means leukemia of
myeloid (bone marrow origin)
series
Acute blastic It involves immature
cells
Chronic and cytic It involves mature
cells
PATHOPHYSIOLOGY
Proliferation of immature WBC (blast)
Competition for nutrients infiltration of organs and
replacement of normal cells by leukemia
Bone marrow reticulo CNS generalised
Dysfunction endothelial hypermetabo
system lism
RBC WBC Platelets
Anemia infection hemorrhage
Reticulo endothelial system
Enlarged liver lymphnodes and spleen
CNS
Leukemia meningitis
Generalized hypermetabolism
Cellular starvation
a)Bone marrow Dsyfunction:
In alltypes of leukemia ,the proleerating
cells depress bone marrow production of
formed elements of the blood by competing
for nutrients and depriving the normal cells of
essential nutrients requered for cellular
metabolism
The main consequencu of bone
marrow dysfunction
 Anemia due to reduced RBC
 Infection due to neutropenia
 Bleeding tendencies due to reduced
platelet count
 Invasion of bone marrow with leukemia
cells causesthe weakening of bones
and tendency towards fracture
 The most frequent presenting sign and
symptoms of leukemia occur due to
infiltration of bone marrow
There feature include
 Fever
 Pallor
 Fatigue
 Anorexia
 Haemorrhage
 Bone and joint pain
b) Infiltration into organs
The blood forming organs like liver, spleen and
lymph glands demonstrate marked infiltration ,
enlargement and eventually fibrosis
C) The immense metabolic needs of proliferating
leukemia cells deprive all body cells of nutrients
necessary for survival
The results is muscle wasting weight loss, anorexia and
CLASSIFICATION
I.ACUTE LYMPHOID LEUKEMIA;
Acute lymphoid or acute lymphocytic
leukaemia is the most commonly diagnosed
cancer in children which accounts for 80% of
all children leukaemia
Acute lymphocytic leukaemia develops
when lymphoid cell line is affected
Causes:
viruses
Irradiation
Exposure to certain toxic chemicals
Drugs
Genetic predisposition
Types of Acute Lymphoid leukaemia
T-cell B Cell Pre B Cell Null cell
a) T Cell leukaemia:
it is seen in 10-15 % cases of acute lymphocytic leukaemia
it is seen in older children ,Particulary males
Signs Symptoms :
Mediastinal mass
Hepato Spleenomegaly
High WBC Count
CNS involvement may be seen
Poor prognosis
b) B Cell Leukemia :
It is seen in 1-2% children will Acute lymphoid leukemia
It is an aggressive form and has poor progressive
C) Pre B Cell:
It has good prognosis and responds well to therapy
d) Null cell Leukemia:
The most common type of children .All occurring in 75%
cases
It has better prognosis that other types
II.ACUTE NON LYMPHOID /ACUTE
MYELOID LEUKEMIA
Acute non lymphocytic leukaemia is abnormal
proliferation of monocytes in bone marrow
It is present approximately 15% children with leukaemia
,It has a poor prognosis
TYPES OF AML:
a. Acute Mycloblastic leukaemia
b. Acute Promyclocytic leukaemia
c. Acute Myclomonocytic leukaemia
d. Acute Monocytic leukaemia
e. Acute Erythrocytic leukaemia
Signs Symptoms:
Recurrent chronic infection
fatigue
lymphadenomegaly
hepato Spleenomegaly
Bone or joint pain
pallor
frequent bruising
Gingival hypertrophy may be present
Features of CNS involvement like
 Head ache
 Blurred vision
 Fundal haemorrhage
 Paresis
Other life threatening problems like
 Sluding or clumping of leukaemia cells in small cerebral
capillaries and hyperuricemia
 Thrombocytopenia
DIAGNOSTIC EVALUATION
 History and physical examination
 Peripheral blood smear that contains immature
leucocytes frequently combined with low normal blood
counts
 Bone marrow examination
 Blood investigation reveal an
 Elevated serum uric acid level due to increased turnover
of malignant cells
 Radiology: done to evaluate the mediastinal mass
 Liver and renal function test are done
 To detect leukemic cells infiltration in liver and kidneys
 Lumber puncture: is done to assess CNS involvement
 Cyto chemical markers
 Leukaemia cells demonstrate different reaction when they
are exposed to certain chemicals
Chromosomal Studies :
Chromosomal analysis become an important tool in the
diagnosis if ALL
For Eg:
i. Children with trisomy 21 have 15times risk of other
children for developing ALL
ii. children who are hyper diploid (more chromosoma)
have a better prognosis
iii. Translocation of chromosome is associated with
better prognosis
 Cell surface antigens have permitted
differentiation of ALL into
3 broad classes
 Non T
non B Cell (all called earley Pre B Cell)
 B Cell ALL
 T Cell ALL
 Children with non T, non B ALL have the best prognosis
,especially it they have the common acute lymphocytic
leukaemia positive on their cell surface
 TLC which may exceed 1,00,000/c mm with all forms of
myeloid cells and remarkable eosinophilia and basophile
TREATMENT
Treatment of leukaemia involve the use of
chemotherapeutic agents with or with out cranial irradiation
A) Chemotherapy :
1.Induction phase
2.Consolidation phase
3.Maintenance Therapy
Induction Phase:
This is the phase that reduces leukaemia cells to an
undetectable level, a state known as remission
In remission there is no evidence of leukaemia on
physical examination ,bone marrow evaluation ,pheri pheral
blood smear ,CSF examination or examination of other extra
medullary sites.
 95% children with leukaemia achieve remission during
induction within 4 weeks
 Drugs used for induction in ALL are:
 Prednisolone
 Vincristine
 L-asparaginase with or with out doxorilbicin
 In AML for induction drugs are
 eyrarabine (era-c)
 daunorubicin
 Leukaemia cells can cross the blood brain barriers while
most chemotherapy drugs ,do not cross this barriers
 Children with ALL receive CNS prophylaxis with
chemotherapy drugs instilled during LP
 Children who present with CNS disease also need 
radiation therapy
Consolidation phase/Intensification:
The rent phase of treatment is consolidation or
intensification that aims at eradicating any residual
leukaemia cells
This phase of therapy begins onc remission is attained
treatment is directed at those anatomic sites which are
protected to some extent from systemic chemotherapy like
CNS
(protected by blood brain barriers ) and testes that lie outside
the body.
This phase involves prophylactic treatment of CNS with
cranial irradiation or intrathecal administration of
methotrexate
methotrexate:
This therapy usually conists of daily high dose
radiation treatment for about 2 weeks or twice a week doses
of methotrexate , a total of 5-6 injections
3. Maintenance therapy:
Aims at preventing recurrence or further reducing the
number of leukemic cells
maintenance therapy begins after successful completion
of induction and consolidation phase
Drugs frequently used in maintenance therapy are 6
macaptopurm and weekly doses of oral methorexate
During this phase weekly or monthly complete blood
count is done to evaluate marrow s response to drugs
If WBC counts gas below 2000/mm3 or toxic side
effects occur than therapy is temporarily stopped or dose is
reduced
B. Bone marrow transplantation :
Bone marrow transplants have been used successfully in
treating some children wit ALL and ANL
In general bone marrow transplant is not recommended for
children with ALL because of excellent results possible with
chemotherapy
marrow transplant is possible only when suitable donor is
available
Prognosis:
After transplantation depends on type of leukaemia
Long term survival after marrow transplant is seen in 25% -
50% cares
Nursing management
a) Management of problems of leukaemia
 Management of anaemia:
• Nurses should assess the leukaemia children for anaemia
and its severity
• Blood transfusion with packed red cells may be required to
raise Hb level above 10gm /dl
• Nurses should take all precaution to prevent problems
associated with blood transfusion like
Transmission of blood borne infection to the patient to
the patient through transfusion of contaminated blood
,transfusion reaction etc.
 Prevention from infection:
broad spectrum antibiotics
live vaccine
universal precaution
isolation
barriers Nursing
strict hand washing
aseptic techniques
Fever is a sign of infection ,so it fever occurs
blood ,urine , stool and nasopharyngeal cultures are
done  to identify the cause and site of infection
Adequate protein and calories intake provides the child
with better host defence against infection and increase
tolerance to chemotherapy
3.Prevention and management of haemorrhage
 administer platelets
 Regular mouth care
 Use soft tooth brush
 The children develop repeated episodes of diarrhoea, so
they prone to rectal ulceration
 During bleeding episodes ,the parents and child need
B) Management of side effects of chemotherapy and
problems of irradiation
 Nausea and Vomiting
 Antemitics promethezine
chlorpromazine
Metaclopramole
Severe vomiting
 Anorexia :
Small and frequent feed
Soft and early digestible food
Serve the food attractive manner
 Mucoal ulceration:
Give bland ,moist and soft diet to the child
Use soft brust on cotton tipped application and mouth wash
Frequent mouth wash with normal saline
Local anaesthetics
Liberal fluid intake
Nasogastric feeds
 Neuropathy
Vincristine ,vinblastine
The child suffer from constipation
 Hemorrhagic cystitis
 Alopecia
The drugs cyclophosphamide leads to haemorrhage cystitis
.It can be presented by
liberal fluid intake
motivate the child to void immediately on feeding the
urge to urinate
administered chemotherapy drugs in the morning
,to allow for sufficient intake of oral fluids
 Mood changes
Shortly after starting of steroid therapy, children
experience mood change with range from feeling of well
being and euphoria depression and irritability
Parental support and guidance
Nurses should coutinually guide support and help
parents to adjust to this disease condition
parents should be encouraged to express their feelings,
fear , grief and concerns
Provide emotional support to the parents continuouslyas
NURSING DIAGNOSIS
 High risk for injury physiologic due to bone marrow
suppression ,infection associated with the proliferature
production of beta cells and the resultant disease in
normal levels of mature blood cells
 High risk for impaired skin integrity, alteration in oral
mucosa , risk factors the effets of cytotoxic drugs or
rapidly dividing mucosal cells
 Altered nutrition less than body requirement rlt dysphagia
associated with stomatitis ,anorexia associated with
nausea and vomiting
 Fluid volume and electrolytic deficit rlt to inadequate fluid
intake associated with stomatitis ,anorexia or nausea
caused by chemotherapy
 Fear and anxiety rlt perception about diagnosis of a life
threatening procedure, hospital environment
 Disturbance in body image self esteem disturbance
altered role performance personal identify disturbance rlt
child and family perception regarding

More Related Content

Similar to LEUKEMIA 1.pptx

Similar to LEUKEMIA 1.pptx (20)

ALL management
ALL managementALL management
ALL management
 
Leukemia
LeukemiaLeukemia
Leukemia
 
leukemia
leukemialeukemia
leukemia
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Leukemia english
Leukemia englishLeukemia english
Leukemia english
 
Leukemia & lymphoma
Leukemia & lymphomaLeukemia & lymphoma
Leukemia & lymphoma
 
LEUKEMIA.pptx
LEUKEMIA.pptxLEUKEMIA.pptx
LEUKEMIA.pptx
 
Leukemia.pptx
Leukemia.pptxLeukemia.pptx
Leukemia.pptx
 
Childhood acute lympocytic leukemia
Childhood acute lympocytic leukemiaChildhood acute lympocytic leukemia
Childhood acute lympocytic leukemia
 
LEUKEMIAS.pptx
LEUKEMIAS.pptxLEUKEMIAS.pptx
LEUKEMIAS.pptx
 
Leukemia in children
Leukemia in childrenLeukemia in children
Leukemia in children
 
LEUKEMIA.pptx
LEUKEMIA.pptxLEUKEMIA.pptx
LEUKEMIA.pptx
 
Leukemia
Leukemia Leukemia
Leukemia
 
Leukomias.pptx
Leukomias.pptxLeukomias.pptx
Leukomias.pptx
 
LEUKAEMIA, DENTAL APPLICATIONS
LEUKAEMIA, DENTAL APPLICATIONSLEUKAEMIA, DENTAL APPLICATIONS
LEUKAEMIA, DENTAL APPLICATIONS
 
Leukaemia lecture 02 ALL transcript
Leukaemia lecture 02   ALL transcriptLeukaemia lecture 02   ALL transcript
Leukaemia lecture 02 ALL transcript
 
leukemias.ppt
leukemias.pptleukemias.ppt
leukemias.ppt
 
An update of Acute leukemia in children.ppt
An update of Acute leukemia in children.pptAn update of Acute leukemia in children.ppt
An update of Acute leukemia in children.ppt
 
leukemia in children with difference btw all and bll
leukemia in children with difference btw all and bllleukemia in children with difference btw all and bll
leukemia in children with difference btw all and bll
 
Leukemia
LeukemiaLeukemia
Leukemia
 

More from GrashiaBlessy1

CLEFT LIP AND PALATE.pptx
CLEFT LIP AND PALATE.pptxCLEFT LIP AND PALATE.pptx
CLEFT LIP AND PALATE.pptxGrashiaBlessy1
 
ANEMIA IN CHILDREN.pptx
ANEMIA IN CHILDREN.pptxANEMIA IN CHILDREN.pptx
ANEMIA IN CHILDREN.pptxGrashiaBlessy1
 
CHRONIC RENAL FAILURE.pptx
CHRONIC RENAL FAILURE.pptxCHRONIC RENAL FAILURE.pptx
CHRONIC RENAL FAILURE.pptxGrashiaBlessy1
 
ACUTE RENAL FAILURE.pptx
ACUTE RENAL FAILURE.pptxACUTE RENAL FAILURE.pptx
ACUTE RENAL FAILURE.pptxGrashiaBlessy1
 
Nephrotic Syndrome.pptx
Nephrotic  Syndrome.pptxNephrotic  Syndrome.pptx
Nephrotic Syndrome.pptxGrashiaBlessy1
 
Glomerulo NephritiS.pptx
Glomerulo  NephritiS.pptxGlomerulo  NephritiS.pptx
Glomerulo NephritiS.pptxGrashiaBlessy1
 
CONGENITAL GENITO URINARY DISORDERS.pptx
CONGENITAL GENITO URINARY DISORDERS.pptxCONGENITAL GENITO URINARY DISORDERS.pptx
CONGENITAL GENITO URINARY DISORDERS.pptxGrashiaBlessy1
 
congenital_anomalies_of_urinary_bladder.ppt
congenital_anomalies_of_urinary_bladder.pptcongenital_anomalies_of_urinary_bladder.ppt
congenital_anomalies_of_urinary_bladder.pptGrashiaBlessy1
 
Tricuspid atresia.pptx
Tricuspid atresia.pptxTricuspid atresia.pptx
Tricuspid atresia.pptxGrashiaBlessy1
 
ACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptxACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptxGrashiaBlessy1
 
LEVELS OF NEONATAL CARE I,II,III.pptx
LEVELS OF NEONATAL CARE I,II,III.pptxLEVELS OF NEONATAL CARE I,II,III.pptx
LEVELS OF NEONATAL CARE I,II,III.pptxGrashiaBlessy1
 
ACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptxACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptxGrashiaBlessy1
 
ANORECTAL MALFORMATION.pptx
ANORECTAL MALFORMATION.pptxANORECTAL MALFORMATION.pptx
ANORECTAL MALFORMATION.pptxGrashiaBlessy1
 
GASTROSCHISIS AND OMPHALOCELE.pptx
GASTROSCHISIS  AND OMPHALOCELE.pptxGASTROSCHISIS  AND OMPHALOCELE.pptx
GASTROSCHISIS AND OMPHALOCELE.pptxGrashiaBlessy1
 
DEVELOPMENT OF CANCER.pptx
DEVELOPMENT OF CANCER.pptxDEVELOPMENT OF CANCER.pptx
DEVELOPMENT OF CANCER.pptxGrashiaBlessy1
 

More from GrashiaBlessy1 (20)

CLEFT LIP AND PALATE.pptx
CLEFT LIP AND PALATE.pptxCLEFT LIP AND PALATE.pptx
CLEFT LIP AND PALATE.pptx
 
THALASSEMIA.pptx
THALASSEMIA.pptxTHALASSEMIA.pptx
THALASSEMIA.pptx
 
ANEMIA IN CHILDREN.pptx
ANEMIA IN CHILDREN.pptxANEMIA IN CHILDREN.pptx
ANEMIA IN CHILDREN.pptx
 
CHRONIC RENAL FAILURE.pptx
CHRONIC RENAL FAILURE.pptxCHRONIC RENAL FAILURE.pptx
CHRONIC RENAL FAILURE.pptx
 
ACUTE RENAL FAILURE.pptx
ACUTE RENAL FAILURE.pptxACUTE RENAL FAILURE.pptx
ACUTE RENAL FAILURE.pptx
 
Nephrotic Syndrome.pptx
Nephrotic  Syndrome.pptxNephrotic  Syndrome.pptx
Nephrotic Syndrome.pptx
 
Glomerulo NephritiS.pptx
Glomerulo  NephritiS.pptxGlomerulo  NephritiS.pptx
Glomerulo NephritiS.pptx
 
CONGENITAL GENITO URINARY DISORDERS.pptx
CONGENITAL GENITO URINARY DISORDERS.pptxCONGENITAL GENITO URINARY DISORDERS.pptx
CONGENITAL GENITO URINARY DISORDERS.pptx
 
congenital_anomalies_of_urinary_bladder.ppt
congenital_anomalies_of_urinary_bladder.pptcongenital_anomalies_of_urinary_bladder.ppt
congenital_anomalies_of_urinary_bladder.ppt
 
Tricuspid atresia.pptx
Tricuspid atresia.pptxTricuspid atresia.pptx
Tricuspid atresia.pptx
 
TOF.pptx
TOF.pptxTOF.pptx
TOF.pptx
 
AORTIC STENOSIS.pptx
AORTIC STENOSIS.pptxAORTIC STENOSIS.pptx
AORTIC STENOSIS.pptx
 
ACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptxACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptx
 
LEVELS OF NEONATAL CARE I,II,III.pptx
LEVELS OF NEONATAL CARE I,II,III.pptxLEVELS OF NEONATAL CARE I,II,III.pptx
LEVELS OF NEONATAL CARE I,II,III.pptx
 
ACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptxACYANOTIC HEART DISEASE.pptx
ACYANOTIC HEART DISEASE.pptx
 
ANORECTAL MALFORMATION.pptx
ANORECTAL MALFORMATION.pptxANORECTAL MALFORMATION.pptx
ANORECTAL MALFORMATION.pptx
 
HITAL HERINA.pptx
HITAL HERINA.pptxHITAL HERINA.pptx
HITAL HERINA.pptx
 
GASTROSCHISIS AND OMPHALOCELE.pptx
GASTROSCHISIS  AND OMPHALOCELE.pptxGASTROSCHISIS  AND OMPHALOCELE.pptx
GASTROSCHISIS AND OMPHALOCELE.pptx
 
DUODENAL ATRESIA.pdf
DUODENAL ATRESIA.pdfDUODENAL ATRESIA.pdf
DUODENAL ATRESIA.pdf
 
DEVELOPMENT OF CANCER.pptx
DEVELOPMENT OF CANCER.pptxDEVELOPMENT OF CANCER.pptx
DEVELOPMENT OF CANCER.pptx
 

Recently uploaded

Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 

Recently uploaded (20)

Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 

LEUKEMIA 1.pptx

  • 1. LEUKEMIA BLOOD CANCER OF BLOOD FORMING TISSUES
  • 3. INCIDENCE Most common malignancy of children less than 15 years of age Peak incidence is at 4 years of age
  • 4. CAUSES Virus papilloma virus ,epstein barr virus,radiations Exposure to chemicals drug like  Benzene  dilantin
  • 5. CLASSIFICATION  Leukemia can be classified as follows leukemia Acute Chronic Acute Acute myeloid leukaemia lymphoid leukaemia
  • 6. Chronic Chronic lymphoid Chronic myloid leukemia leukemia T-cell Bcell pre B cell null cell
  • 7.  Acute myeloid leukemia Acute Acute Acute myelo mono Myeloblastic promyelocytic cytic acute mono cytic Acute erythro cytic
  • 8. Leukaemia can be classified according to pre dominent cell type and level of cell maturity as:  lympho It means leukemia involving the lymphoid series  Myelo It means leukemia of myeloid (bone marrow origin) series
  • 9. Acute blastic It involves immature cells Chronic and cytic It involves mature cells
  • 10. PATHOPHYSIOLOGY Proliferation of immature WBC (blast) Competition for nutrients infiltration of organs and replacement of normal cells by leukemia Bone marrow reticulo CNS generalised Dysfunction endothelial hypermetabo system lism
  • 11. RBC WBC Platelets Anemia infection hemorrhage
  • 12. Reticulo endothelial system Enlarged liver lymphnodes and spleen CNS Leukemia meningitis Generalized hypermetabolism Cellular starvation
  • 13. a)Bone marrow Dsyfunction: In alltypes of leukemia ,the proleerating cells depress bone marrow production of formed elements of the blood by competing for nutrients and depriving the normal cells of essential nutrients requered for cellular metabolism The main consequencu of bone marrow dysfunction
  • 14.  Anemia due to reduced RBC  Infection due to neutropenia  Bleeding tendencies due to reduced platelet count  Invasion of bone marrow with leukemia cells causesthe weakening of bones and tendency towards fracture  The most frequent presenting sign and symptoms of leukemia occur due to infiltration of bone marrow
  • 15. There feature include  Fever  Pallor  Fatigue  Anorexia  Haemorrhage  Bone and joint pain
  • 16. b) Infiltration into organs The blood forming organs like liver, spleen and lymph glands demonstrate marked infiltration , enlargement and eventually fibrosis C) The immense metabolic needs of proliferating leukemia cells deprive all body cells of nutrients necessary for survival The results is muscle wasting weight loss, anorexia and
  • 17. CLASSIFICATION I.ACUTE LYMPHOID LEUKEMIA; Acute lymphoid or acute lymphocytic leukaemia is the most commonly diagnosed cancer in children which accounts for 80% of all children leukaemia Acute lymphocytic leukaemia develops when lymphoid cell line is affected
  • 18. Causes: viruses Irradiation Exposure to certain toxic chemicals Drugs Genetic predisposition
  • 19. Types of Acute Lymphoid leukaemia T-cell B Cell Pre B Cell Null cell
  • 20. a) T Cell leukaemia: it is seen in 10-15 % cases of acute lymphocytic leukaemia it is seen in older children ,Particulary males Signs Symptoms : Mediastinal mass Hepato Spleenomegaly High WBC Count CNS involvement may be seen Poor prognosis
  • 21. b) B Cell Leukemia : It is seen in 1-2% children will Acute lymphoid leukemia It is an aggressive form and has poor progressive C) Pre B Cell: It has good prognosis and responds well to therapy
  • 22. d) Null cell Leukemia: The most common type of children .All occurring in 75% cases It has better prognosis that other types
  • 23. II.ACUTE NON LYMPHOID /ACUTE MYELOID LEUKEMIA Acute non lymphocytic leukaemia is abnormal proliferation of monocytes in bone marrow It is present approximately 15% children with leukaemia ,It has a poor prognosis
  • 24. TYPES OF AML: a. Acute Mycloblastic leukaemia b. Acute Promyclocytic leukaemia c. Acute Myclomonocytic leukaemia d. Acute Monocytic leukaemia e. Acute Erythrocytic leukaemia
  • 25. Signs Symptoms: Recurrent chronic infection fatigue lymphadenomegaly hepato Spleenomegaly Bone or joint pain pallor frequent bruising
  • 26. Gingival hypertrophy may be present Features of CNS involvement like  Head ache  Blurred vision  Fundal haemorrhage  Paresis Other life threatening problems like  Sluding or clumping of leukaemia cells in small cerebral capillaries and hyperuricemia  Thrombocytopenia
  • 27. DIAGNOSTIC EVALUATION  History and physical examination  Peripheral blood smear that contains immature leucocytes frequently combined with low normal blood counts  Bone marrow examination  Blood investigation reveal an  Elevated serum uric acid level due to increased turnover of malignant cells  Radiology: done to evaluate the mediastinal mass
  • 28.  Liver and renal function test are done  To detect leukemic cells infiltration in liver and kidneys  Lumber puncture: is done to assess CNS involvement  Cyto chemical markers  Leukaemia cells demonstrate different reaction when they are exposed to certain chemicals
  • 29. Chromosomal Studies : Chromosomal analysis become an important tool in the diagnosis if ALL For Eg: i. Children with trisomy 21 have 15times risk of other children for developing ALL ii. children who are hyper diploid (more chromosoma) have a better prognosis
  • 30. iii. Translocation of chromosome is associated with better prognosis  Cell surface antigens have permitted differentiation of ALL into 3 broad classes  Non T non B Cell (all called earley Pre B Cell)  B Cell ALL  T Cell ALL
  • 31.  Children with non T, non B ALL have the best prognosis ,especially it they have the common acute lymphocytic leukaemia positive on their cell surface  TLC which may exceed 1,00,000/c mm with all forms of myeloid cells and remarkable eosinophilia and basophile
  • 32. TREATMENT Treatment of leukaemia involve the use of chemotherapeutic agents with or with out cranial irradiation A) Chemotherapy : 1.Induction phase 2.Consolidation phase 3.Maintenance Therapy
  • 33. Induction Phase: This is the phase that reduces leukaemia cells to an undetectable level, a state known as remission In remission there is no evidence of leukaemia on physical examination ,bone marrow evaluation ,pheri pheral blood smear ,CSF examination or examination of other extra medullary sites.
  • 34.  95% children with leukaemia achieve remission during induction within 4 weeks  Drugs used for induction in ALL are:  Prednisolone  Vincristine  L-asparaginase with or with out doxorilbicin  In AML for induction drugs are  eyrarabine (era-c)  daunorubicin
  • 35.  Leukaemia cells can cross the blood brain barriers while most chemotherapy drugs ,do not cross this barriers  Children with ALL receive CNS prophylaxis with chemotherapy drugs instilled during LP  Children who present with CNS disease also need  radiation therapy
  • 36. Consolidation phase/Intensification: The rent phase of treatment is consolidation or intensification that aims at eradicating any residual leukaemia cells This phase of therapy begins onc remission is attained treatment is directed at those anatomic sites which are protected to some extent from systemic chemotherapy like CNS (protected by blood brain barriers ) and testes that lie outside the body.
  • 37. This phase involves prophylactic treatment of CNS with cranial irradiation or intrathecal administration of methotrexate methotrexate: This therapy usually conists of daily high dose radiation treatment for about 2 weeks or twice a week doses of methotrexate , a total of 5-6 injections
  • 38. 3. Maintenance therapy: Aims at preventing recurrence or further reducing the number of leukemic cells maintenance therapy begins after successful completion of induction and consolidation phase Drugs frequently used in maintenance therapy are 6 macaptopurm and weekly doses of oral methorexate
  • 39. During this phase weekly or monthly complete blood count is done to evaluate marrow s response to drugs If WBC counts gas below 2000/mm3 or toxic side effects occur than therapy is temporarily stopped or dose is reduced
  • 40. B. Bone marrow transplantation : Bone marrow transplants have been used successfully in treating some children wit ALL and ANL In general bone marrow transplant is not recommended for children with ALL because of excellent results possible with chemotherapy marrow transplant is possible only when suitable donor is available Prognosis: After transplantation depends on type of leukaemia Long term survival after marrow transplant is seen in 25% - 50% cares
  • 41. Nursing management a) Management of problems of leukaemia  Management of anaemia: • Nurses should assess the leukaemia children for anaemia and its severity • Blood transfusion with packed red cells may be required to raise Hb level above 10gm /dl • Nurses should take all precaution to prevent problems associated with blood transfusion like
  • 42. Transmission of blood borne infection to the patient to the patient through transfusion of contaminated blood ,transfusion reaction etc.  Prevention from infection: broad spectrum antibiotics live vaccine universal precaution isolation
  • 43. barriers Nursing strict hand washing aseptic techniques Fever is a sign of infection ,so it fever occurs blood ,urine , stool and nasopharyngeal cultures are done  to identify the cause and site of infection
  • 44. Adequate protein and calories intake provides the child with better host defence against infection and increase tolerance to chemotherapy 3.Prevention and management of haemorrhage  administer platelets  Regular mouth care  Use soft tooth brush  The children develop repeated episodes of diarrhoea, so they prone to rectal ulceration  During bleeding episodes ,the parents and child need
  • 45. B) Management of side effects of chemotherapy and problems of irradiation  Nausea and Vomiting  Antemitics promethezine chlorpromazine Metaclopramole Severe vomiting
  • 46.  Anorexia : Small and frequent feed Soft and early digestible food Serve the food attractive manner  Mucoal ulceration: Give bland ,moist and soft diet to the child Use soft brust on cotton tipped application and mouth wash Frequent mouth wash with normal saline
  • 47. Local anaesthetics Liberal fluid intake Nasogastric feeds  Neuropathy Vincristine ,vinblastine The child suffer from constipation  Hemorrhagic cystitis  Alopecia
  • 48. The drugs cyclophosphamide leads to haemorrhage cystitis .It can be presented by liberal fluid intake motivate the child to void immediately on feeding the urge to urinate administered chemotherapy drugs in the morning ,to allow for sufficient intake of oral fluids
  • 49.  Mood changes Shortly after starting of steroid therapy, children experience mood change with range from feeling of well being and euphoria depression and irritability Parental support and guidance Nurses should coutinually guide support and help parents to adjust to this disease condition
  • 50. parents should be encouraged to express their feelings, fear , grief and concerns Provide emotional support to the parents continuouslyas
  • 51. NURSING DIAGNOSIS  High risk for injury physiologic due to bone marrow suppression ,infection associated with the proliferature production of beta cells and the resultant disease in normal levels of mature blood cells  High risk for impaired skin integrity, alteration in oral mucosa , risk factors the effets of cytotoxic drugs or rapidly dividing mucosal cells
  • 52.  Altered nutrition less than body requirement rlt dysphagia associated with stomatitis ,anorexia associated with nausea and vomiting  Fluid volume and electrolytic deficit rlt to inadequate fluid intake associated with stomatitis ,anorexia or nausea caused by chemotherapy
  • 53.  Fear and anxiety rlt perception about diagnosis of a life threatening procedure, hospital environment  Disturbance in body image self esteem disturbance altered role performance personal identify disturbance rlt child and family perception regarding